ViewRay`s MRIdian to be Featured at Leading European Radiation Oncology Meeting
(WorldNews Business)

CLEVELAND, April 23, 2019 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that the company`s MRIdian MRI-guided radiation therapy system will be featured at the Annual Meeting of the European Society for Radiotherapy and Oncology (ESTRO), with a number of presentations and posters highlighting MRIdian research and clinical experience. The ESTRO meeting will be held April 26-30 in Milan, Italy. MRIdian MRI-guided radiation therapy offers continuous, high-quality soft tissue visualization and automated beam-gating to improve the accuracy and precision of cancer treatment. The significant interest around MRIdian is reflected in more than 25 MRIdian presentations and posters...